CONTACT US
Share: Share on Facebook Share on Twitter Share on LinkedIn I recommend visiting cushmanwakefield.com to read:%0A%0A {0} %0A%0A {1}

High-Quality $140m Healthcare Portfolio Hits the Market

Jess Freeman • 20/04/2022

20 April 2022 – A portfolio of high-quality healthcare real estate assets, which are geographically dispersed throughout Australia and underpinned by high-calibre operators, has been brought to market, providing a rare opportunity to invest in turnkey properties.

The $140million nine-asset healthcare portfolio is jointly marketed by Cushman & Wakefield and JLL. The properties include five QLD IPN_Forest_Lake_Drone asset, two VIC assets, a NSW asset and a WA asset. The properties are divested by the seven-year established, unlisted closed-end fund, Centuria Healthcare Direct Medical Fund No. 1.

The healthcare real estate market has experienced significant maturity within the past seven years and the divestment is set to capture the sector’s strong tailwinds, which are supported by sustainable market fundamentals such as limited supply, an ageing population and increasing operator demand.

The assets are to be sold individually in any combination, or in one-line through Mike Walsh, Peter Court and Frederic Le Fanue of Cushman & Wakefield and Simon Quinn, Elliott O’Shea, Nigel Freshwater and Mark Stafford of JLL.

According to Mike Walsh of Cushman & Wakefield, the portfolio is expected to be hotly contested given the appetite for the medical / healthcare asset class across Australia.

“This is set to be one of the most anticipated portfolio sales of 2022 - providing scale, geographical diversification and exposure to a highly sought-after asset class.

“The portfolio boasts a strong tenancy profile, underpinned by a mix of blue chip tenants and a highly desired range of uses including Private Hospitals, Medical Specialist Centres and Mental Health facilities to name a few.”

Simon Quinn of JLL stated “We have seen an influx of investor demand for healthcare assets, with capital being drawn to the sector’s defensive and non-cyclical income streams.

“We expect significant interest, locally and off-shore from a wide range of Institutional, Syndication & Private Capital groups” he said.

This national portfolio is for sale via EOI closing on Thursday 2 June 2022.

How can we help?

Get in touch with one of our professionals.

Recent Media Releases

CushWake-QLD-Investment-Sales-team.jpg
Cushman & Wakefield expands Investment Sales team with seven new appointments

Global real estate firm Cushman & Wakefield has strengthened its Investment Sales team with the appointment of seven new professionals across Australia, further reinforcing its presence in key markets.

Jess Freeman • 26/03/2025

78 Albert Rd 2.png
Premier Equine facility & luxury development opportunity hits the market

One of South East Queensland’s most prestigious equine properties, Grand Parkview Stud, is set to hit the market with Development Approval (DA) for a 12-lot luxury estate subdivision, paving the way for an exclusive, high-end acreage development catering to discerning buyers seeking a blend of luxury living and equestrian excellence.

Jess Freeman • 25/03/2025

6-12-Warley-Avenue-Cowes
Permit-approved coastal development opportunity hits the market in Cowes

A rare and highly sought-after development opportunity has emerged in one of Victoria’s most prestigious coastal destinations. The permit-approved site at 6-12 Warley Avenue, Cowes, offers developers the chance to deliver a luxury residential project with panoramic bay views in a region experiencing increasing demand for premium coastal living.

Jess Freeman • 14/03/2025

With your permission we and our partners would like to use cookies in order to access and record information and process personal data, such as unique identifiers and standard information sent by a device to ensure our website performs as expected, to develop and improve our products, and for advertising and insight purposes.

Alternatively click on More Options and select your preferences before providing or refusing consent. Some processing of your personal data may not require your consent, but you have a right to object to such processing.

You can change your preferences at any time by returning to this site or clicking on Privacy & Cookies.
MORE OPTIONS
AGREE AND CLOSE
These cookies ensure that our website performs as expected,for example website traffic load is balanced across our servers to prevent our website from crashing during particularly high usage.
These cookies allow our website to remember choices you make (such as your user name, language or the region you are in) and provide enhanced features. These cookies do not gather any information about you that could be used for advertising or remember where you have been on the internet.
These cookies allow us to work with our marketing partners to understand which ads or links you have clicked on before arriving on our website or to help us make our advertising more relevant to you.
Agree All
Reject All
SAVE SETTINGS